DFCM
RCUS icon

Dark Forest Capital Management’s Arcus Biosciences RCUS Stock Holding History

Dark Forest Capital Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-60,614
Closed -$1.44M – 1080
2025
Q4 		$1.44M Sell
60,614
-79,407
-57% -$1.62M 0.07% 520
2025
Q3 		$1.9M Sell
140,021
-142,650
-50% -$1.48M 0.07% 481
2025
Q2 		$2.3M Buy
282,671
+205,462
+266% +$1.75M 0.09% 394
2025
Q1 		$606K Buy
77,209
+47,007
+156% +$545K 0.03% 864
2024
Q4 		$450K Buy
30,202
+15,308
+103% +$250K 0.07% 486
2024
Q3 		$228K Buy
+14,894
New +$235K 0.03% 811
2024
Q2 		– Sell
-35,590
Closed -$672K – 856
2024
Q1 		$672K Buy
+35,590
New +$615K 0.11% 186
2023
Q4 		– Sell
-38,224
Closed -$686K – 970
2023
Q3 		$686K Buy
+38,224
New +$768K 0.05% 576
2022
Q2 		– Sell
-38,737
Closed -$1.22M – 1291
2022
Q1 		$1.22M Buy
38,737
+38,588
+25,898% +$1.29M 0.29% 89
2021
Q4 		$6K Buy
+149
New +$5.78K ﹤0.01% 1105

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Dark Forest Capital Management's RCUS Position: Q1 2026 in Review

Dark Forest Capital Management sold out of Arcus Biosciences (RCUS) in Q1 2026, closing a stake of 60,614 shares — an estimated $1.44M sold.

Dark Forest Capital Management first reported a position in RCUS in Q4 2021 and held it in 10 quarters. The position peaked at $2.3M in Q2 2025. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Dark Forest Capital Management reported no remaining Arcus Biosciences position as of Q1 2026 after selling out during the quarter.
  • Dark Forest Capital Management sold 60,614 Arcus Biosciences shares in Q1 2026, an estimated $1.44M.
  • Dark Forest Capital Management first reported a position in Arcus Biosciences in Q4 2021 and held it in 10 quarters.
  • Dark Forest Capital Management's Arcus Biosciences position peaked at $2.3M in Q2 2025.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Dark Forest Capital Management's 13F filing for Q1 2026, filed 15 May 2026.